Ipamorelin: How It Works, Research, and Safety
As researchers study various substances’ effects on the hormone balance within the human body, interest in peptides has grown significantly. Ipamorelin, however, is one such compound that has stood out in association with the release of growth hormone. The fact that the ipamorelin compound is not a direct use of growth hormone but rather interacts through the receptors along the body’s signaling pathway has made it a viable topic for study, even though lots of the hypotheses associated with any real-life advantages are yet to be definitely proven in the human body.
How Does It Work?
Ipamorelin is basically considered to be a growth hormone secretagogue. This is certainly a class of substance which actually triggers the pituitary gland to secrete growth hormone rather than acting directly.
The GHS (growth hormone secretagogue) receptor that this acts upon is known as GHSR. The receptor’s role is also linked to that of ghrelin, a naturally occurring hormone with many roles in the body. Activation of this receptor causes messages to be sent to the pituitary gland resulting in growth hormone secretion.
This differentiates the peptide from molecules that act on the Growth Hormone-Releasing Hormone, Receptor. Thus enabling researchers to investigate multiple ways in which hormonal production can be controlled naturally.
Why Are Researchers Interested in It?
There is a great deal of interest in Ipamorelin due to the broad nature of growth hormone. For example growth hormone is associated with IGF-1 and is involved in many functions including tissue development and energy production.
Therefore it is often referenced in relation to recovery, body composition and sleep. While these possibilities are what lead to further research, they should not be regarded as fact. Just because a compound influences a hormonal pathway doesn’t mean that it will reliably lead to specific physical or health benefits.
What About Safety?
Peptide research for growth hormone stimulation is still in the early stages and these agents’ safety in the long term remains unproven. Alteration of normal hormonal signalling mechanisms may affect a number of other processes; for instance, normal glucose homeostasis, and fluid regulation.
Another issue is the variations between a peptide that has been researched in a laboratory setting and the results produced by uncontrolled suppliers. It is often wondered whether online products are diluted, contaminated or if the label information represents the actual content.
Conclusion
Investigations on this peptide have been helpful in a better understanding of ways in which growth hormone secretion can be modulated by receptor signalling. However, that is not to say it is of any proven medical value. Further more rigorous clinical studies in humans are required before any therapy can be applied in practice.
